dyslipidemia - Cleveland Clinic

Tag debug info: client: {"assets":{},"datasets":{},"live":{},"projects":{},"users":{},"observable":{"assets":{},"datasets":{},"live":{},"projects":{},"users":{}}}
Now: 1770453551577
Cache Key: cqdTagPageBySlug:dyslipidemia
fetchCache[cqdTagPageBySlug:dyslipidemia].expirationTime: falsey
fetchCache[cqdTagPageBySlug:dyslipidemia]. seconds remaining: falsey
All fetchCache expiration times:
-- Key: cqdNotFoundPage, seconds remaining: -499
-- Key: cqdTagPageBySlug:nancy-foldvary-schaefer, seconds remaining: -499
-- Key: cqdPostsByTag:cqd-migrated-tag-2036,1,10, seconds remaining: -428
-- Key: cqdTagPageBySlug:resilience, seconds remaining: -205
-- Key: cqdPostsByTag:cqd-migrated-tag-17130,1,10, seconds remaining: -57
-- Key: cqdTagPageBySlug:emre-gorgun, seconds remaining: 3972
-- Key: cqdPostsByTag:cqd-migrated-tag-2736,1,10, seconds remaining: 4047
-- Key: cqdTagPageBySlug:laparoscopy-caused-hernia, seconds remaining: 4610
-- Key: cqdPostsByTag:cqd-migrated-tag-17911,1,10, seconds remaining: 4712
-- Key: cqdTagPageBySlug:beth-meese, seconds remaining: 6108
-- Key: cqdPostsByTag:cqd-migrated-tag-1425,1,10, seconds remaining: 6180
-- Key: cqdTagPageBySlug:poem, seconds remaining: 7622
-- Key: cqdPostsByTag:cqd-migrated-tag-3818,1,10, seconds remaining: 7774
conditions:
-- false,
-- NA,
-- NA,
-- NA
-- false
Cache miss for key cqdTagPageBySlug:dyslipidemia - retrieving from Sanity
CCCache.dataFetchCount: 1476
Cache cleanup seconds remaining: 19501

Tag: dyslipidemia

CRISPR-Cas9 Gene Editing for Refractory Dyslipidemia Shows Safety and Preliminary Efficacy

Large Cohort Study Reveals Vanishingly Small Rates of Lipoprotein(a) Testing

Lepodisiran’s Large, Durable Lp(a) Reductions in Phase 2 Trial Boost Anticipation of Phase 3 Results

Web App Enables Safe, Effective Nonprescription Statin Use

Link Discovered Between Excess Niacin and Cardiovascular Disease

Lipoprotein(a): Progress on One of the Last Untreatable Frontiers of Cardiovascular Risk

Novel siRNA Reduces Lipoprotein(a) by More Than 90% for 48 Weeks

Dietary Supplements Don’t Stack Up to Low-Dose Statin Therapy for LDL-C Reduction

Novel siRNA Therapy Lowers Elevated Plasma Lipoprotein(a) in Phase 1 APOLLO Trial

Research Reveals Potential Drug Target for Treating Obesity and Other Metabolic Conditions